Tag: Landos
Landos Biopharma Announces 1-for-10 Reverse Stock Split – Landos Biopharma (NASD…...
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. LABP, a clinical-stage biopharmaceutical company developing novel, oral medicines for...
Landos Biopharma to Present at the Raymond James Virtual Human Health...
BLACKSBURG, Va., June 14, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a late clinical-stage biopharmaceutical company utilizing its LANCE...
Landos Biopharma Reports First Quarter 2021 Financial Results and Provides Business...
Completed initial public offering of common stock, raising approximately $100 million in gross proceeds Following positive Phase 2 results of...